Adler Juvebene, Tabletten

7680687450010 CH-68745 Tabletten

Associated product:

ADLER Juvebene cpr bte 400 pce
Adler Juvebene, Tabletten
Adler Juvebene, Tabletten
Adler Juvebene, Tabletten
1 / 3
google

Article details

Package size
400
Selling units
400
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/06/2023
Patient information leaflet
Français
06/06/2023
Patient information leaflet
Italien
06/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
26.0 MG Substance Wirkstoff (Principe actif)
(N/A)
37.0 MG Substance Wirkstoff (Principe actif)
(N/A)
37.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
250.0 MG Substance HBESI

Authorization holder

Adler Pharma Helvetia AG

6060 Sarnen

Authorization information

Swissmedic authorization number
68745
Drug name
Adler Juvebene, Tabletten
Galenic form
TAB
Authorization status
Z
Dispensing category
D
First authorization
23/02/2023
Authorization expiration date
22/02/2028
IT Number
20.01.4.
Domain
Human medicine
Field of application
Gemäss dem biochemischen Therapieprinzip nach Dr. Schüssler bei Glieder- und Knochenschmerzen während der Wachstumsphase im Kindes- und Jugendalter.

Package details

Description (FR)
ADLER Juvebene cpr bte 400 pce
Description (DE)
ADLER Juvebene Tabl Ds 400 Stk
Market launch
23/02/2023
Narcotic (BTM)
No

Other package sizes (1)

None
1000 TABL
GTIN: None
Not in V1